7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,749.04

+353.32

+0.46%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqCM - Delayed Quote USD

Cingulate Inc. (CING)

4.9800 -0.2100 (-4.05%)

At close: October 30 at 4:00:01 PM EDT

Loading Chart for CING

Chart Range Bar

Interval:

In partnership with ChartIQ

Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma

Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma

CING: Second Quarter Results

CING: Second Quarter Results

Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness

Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness

Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®

Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®

Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26

Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26

Cingulate Receives Complete Response Letter from FDA for CTx-1301

Cingulate Receives Complete Response Letter from FDA for CTx-1301

CING: Building Its Cash Position

CING: Building Its Cash Position

Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301

Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301

Here is Why Cingulate (CING) is One of the Best NASDAQ Growth Stocks to Buy and Hold Forever

Here is Why Cingulate (CING) is One of the Best NASDAQ Growth Stocks to Buy and Hold Forever

Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25

Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25

CING: Laying the Foundation for 1H:27 Launch

CING: Laying the Foundation for 1H:27 Launch

Mobilize your Website

View Site in Mobile | Classic

Share by: